An experimental drug appears to help women deal with stress incontinence, clinical trial data show. The drug, for now dubbed TAS-303, reduced the frequency of leaks related to stress incontinence by about 58%, compared with 47% reduction in a placebo group, trial results show. Further, about 65% of patients taking TAS-303 had their stress incontinence… read on > read on >
All Food:
Fake Botox Shots Land 13 Women in Hospital
Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator, a new report warns. In the report, published Thursday by the U.S. Centers for Disease Control and Prevention, researchers provided alarming details of patients getting injections outside of a… read on > read on >
Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle
Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person’s lifestyle, a new study says. Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show. But excess body weight, drinking, lack of exercise, diet and skipping cancer-preventing vaccinations… read on > read on >
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows. Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the review sifted through pharmacy and medical claims data for 3,364 people with insurance plans that cover the GLP-1 drugs. Patients had… read on > read on >
At Least 58 Have Now Been Sickened After Eating Diamond Shruumz Edibles
Nearly 60 illnesses, including 30 hospitalizations, have now been linked to eating Diamond Shruumz edibles, U.S. health officials reported. The U.S. Centers for Disease Control and Prevention noted in an update issued Tuesday that of the people who got sick after eating the recalled chocolate bars, cones and gummies, one patient has died. Those who… read on > read on >
Less Than Half of American Adults Know Dangers of Raw Milk
Few Americans understand the health risks of drinking raw milk, a new survey shows, so experts are redoubling efforts to get the word out on its dangers. The push dovetails with the discovery this spring of bird flu virus in milk from infected cows. The H5N1 virus is widespread in wild birds worldwide and causing… read on > read on >
When Diet, Exercise Delay Diabetes Diagnosis, Long-term Health Improves
Prediabetes can be successfully fought through diet and exercise, a new study shows. People with prediabetes can reduce their long-term risk of death and illness if they use diet and exercise to delay the onset of diabetes for just four years, according to findings published July 9 in the journal PLOS Medicine. Prediabetes — also… read on > read on >
Untreated Water Likely Source of Salmonella Outbreak Linked to Cucumbers
U.S. health officials have determined that untreated water used by a Florida cucumber grower is one likely source of salmonella poisoning that sickened nearly 450 people this spring. Still, that grower didn’t supply all the cucumbers that were linked to salmonella contamination, the U.S. Food and Drug Administration (FDA) noted in a recent health update. During their… read on > read on >
Mounjaro Bests Ozempic for Weight Loss
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic, Wegovy), researchers reported July 8 in the journal JAMA Internal Medicine. “Individuals with overweight or obesity treated with tirzepatide were significantly more likely to achieve clinically meaningful weight loss… read on > read on >
Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers
In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers. In a study published July 5 in JAMA Network Open, researchers found people with type 2 diabetes who were being treated with a class of… read on > read on >